Luc F. Van Gaal

Once-Weekly Semaglutide in Adults with Overweight or Obesity

John Wilding, Rachel L. Batterham, Salvatore Calanna et al. · New England Journal of Medicine · 2021 · 4.5K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

Luc F. Van Gaal, Aila Rissanen, André Scheen et al. · The Lancet · 2005 · 1.5K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects

W. P. T. James, Ian D. Caterson, Walmir Coutinho et al. · New England Journal of Medicine · 2010 · 934 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +9

Weight regain and cardiometabolic effects after withdrawal of semaglutide: The <scp>STEP</scp> 1 trial extension

John Wilding, Rachel L. Batterham, Melanie J. Davies et al. · Diabetes Obesity and Metabolism · 2022 · 921 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Effect of sibutramine on weight maintenance after weight loss: a randomised trial

W. P. T. James, Arne Astrup, Nick Finer et al. · The Lancet · 2000 · 820 citations

Agriculture, Nutritional Sciences, Pharmacotherapy +9